BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hussaini MO, Kreisel FH, Hassan A, Nguyen TT, Frater JL. CD4-positive diffuse large B-cell lymphoma: A variant with aggressive clinical potential. World J Methodol 2016; 6(3): 181-186 [PMID: 27679780 DOI: 10.5662/wjm.v6.i3.181]
URL: https://www.wjgnet.com/2222-0682/full/v6/i3/181.htm
Number Citing Articles
1
Ritu Garg, Pratibha Dhiman, Rajesh Tandon, Bhawna Jha. Double-hit high-grade B-cell lymphoma with aberrant T-cell phenotypeD Y Patil Journal of Health Sciences 2023; 11(4): 187 doi: 10.4103/DYPJ.DYPJ_29_23
2
Wenqi Zhang, Yanfeng Fan, Meng Li, Linqi Yang, Zhenya Zhang, Lihong Liu, Zhongjie Shi. Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL)Disease Markers 2021; 2021: 1 doi: 10.1155/2021/4894022
3
Ilya Zubarev, Dmitry Vladimirtsev, Maria Vorontsova, Igor Blatov, Konstantin Shevchenko, Svetlana Zvereva, Evgenii A. Lunev, Evgeny Faizuloev, Nikolay Barlev. Viral Membrane Fusion Proteins and RNA Sorting Mechanisms for the Molecular Delivery by ExosomesCells 2021; 10(11): 3043 doi: 10.3390/cells10113043
4
Jack Lee, Jason A. Cohen, David A. Wrone, Alejandro A. Gru. Primary cutaneous follicle center lymphoma with aberrant CD8 expressionJournal of Cutaneous Pathology 2022; 49(4): 403 doi: 10.1111/cup.14173
5
Anurag Mehta, Prerna Chadha, Poojan Agarwal, Sunil Pasricha. Aberrant expression of multiple T cell markers on diffuse large B cell lymphoma: a case reportJournal of the Egyptian National Cancer Institute 2021; 33(1) doi: 10.1186/s43046-021-00071-7